Our work indicates that, when there is evidence or presence of familiar defects, it is meaningful to examine children as early as possible for mutations in genes GJB2 and GJB6 in order to promptly identify non-syndromal hearing impairments and, if appropriate, initiate optimal support of speech development by means of hearing aids or cochlear implantation. This evidence concerns the gene GJB6 and hearing loss disorder.